Study | Year | Country | detection method | case (control) | control (benign) | Age (median) | Time-consuming | tumor stage | Cut-off value | sensitivity | Specificity | TP | FP | FN | TN | QUADAS-2 scores |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zeng Y [29] | 2016 | China | RT-qPCR | 40(82) | 82(42) | 49 | 1.5 | I-IV | NR | 0.675 | 0.7857 | 27 | 18 | 13 | 64 | 7 |
Mahmoud [30] | 2018 | Egypt | RT-qPCR | 60(30) | 30(0) | 55.5 | 1 | I, III-IV | 1.005 | 0.967 | 0.8 | 58 | 6 | 2 | 24 | 9 |
Tang M [31] | 2018 | China | RT-qPCR | 162(108) | 108(0) | 54.27 | 4 | I-IV | 1.46 | 0.842 | 0.705 | 136 | 32 | 26 | 76 | 5 |
Li HP [32] | 2019 | China | RT-qPCR | 96(80) | 80(80) | 51.27 | 2 | I-IV | 1.73 | 0.7708 | 0.8125 | 74 | 15 | 22 | 65 | 8 |
You J [33] | 2019 | China | RT-qPCR | 80(100) | 100(50) | 53.68 | 2 | I-IV | 2.13 | 0.788 | 0.92 | 63 | 8 | 17 | 92 | 7 |
Song KW [34] | 2020 | China | RT-qPCR | 86(86) | 86(0) | 46.1 | 1 | I-IV | 1.027 | 0.763 | 0.856 | 66 | 12 | 20 | 74 | 9 |